#China #Shanghai #Pharma #CPHI #PMEC

CPHI & PMEC China 2025: A New Era for Pharma

The upcoming CPHI & PMEC China, scheduled from June 24 to 26, 2025, at the Shanghai New International Expo Center, is set to attract unprecedented international participation, highlighting a reinvigorated momentum in the global pharmaceutical landscape. As global trade dynamics shift positively and investments in the pharmaceutical sector increase, this year's event promises to break previous attendance records.

An anticipated 90,000 attendees and over 12,000 international executives are expected to participate, making it the largest pharma gathering in Asia's history. This surge aligns with other critical market factors, including the easing of trade tariffs, improved valuations within the pharmaceutical industry, and increased capital expenditure across various sectors.

Key trends have emerged from the event; a noteworthy rise in Western pharmaceutical companies' interest in Chinese biotech assets has been observed. These companies are not only looking for access to the Chinese domestic market but also seeking opportunities for global licensing partnerships. This interest is paralleled by a significant increase in participation from Middle Eastern countries, as Gulf nations are committed to establishing regional manufacturing hubs, reflecting a shift in the global supply chain dynamics. Delegations from India and the United States are also participating in larger numbers, eager to explore partnerships and collaborations.

According to Natasha Jennings, Head of Global Growth Marketing, the pharma industry's fundamentals remain robust. “We are witnessing a record number of discoveries and a return to growth in the global pharmaceutical market,” she noted. Jennings emphasized that foreign attendees are now leveraging China’s extensive network of ingredient and manufacturing companies to enhance their global manufacturing capabilities.

The CPHI & PMEC event will also cater to specific industry needs with supplementary programs, such as the Natural Extracts Buyer Programme on June 23 and the Pharma Machinery Buyer Programme from June 24 to 25. The exhibition is set to feature special recognition events, including the CPHI Celebration Awards and a dedicated conference that includes the 10th Biopharmaceuticals Outlook Summit. Additional highlights include an Innovation Gallery and regional plant visits, providing invaluable insights for participants.

Covering more than 230,000 square meters, the event will host 3,500 exhibitors from 150 countries, organized into 12 specialized zones. Notably, this year introduces new zones including 'BioTech' and 'Fluid Precision Equipment'.

With the global pharmaceutical landscape shifting, many executives are keen to extend their supplier networks in China, establishing primary, secondary, and reserve suppliers for strategic long-term planning. Improved trade relations have sparked a renaissance in global pharmaceutical partnerships, signaling an optimistic outlook.

Interested parties can register for the event by visiting CPHI registration page.

In summary, the 2025 edition of CPHI & PMEC China represents a pivotal moment for the pharmaceutical industry, where collaboration, innovation, and strategic partnership formation take center stage, paving the way for growth and development in a changing global landscape.